Letter

Drug combinations and all cause mortality in heart disease: Dosages and types of ACE inhibitors need to be known

BMJ 2005; 331 doi: 10.1136/bmj.331.7509.159-b (Published 14 July 2005)
Cite this as: BMJ 2005;331:159.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Frank A Snyder, physician (slude1@aol.com)
  1. Wilmington Internal Medicine 2215 Canterwood, Wilmington, NC 28401, USA

    EDITOR—The study reported by Hippisley-Cox and Coupland leads to much generalisation.1 Firstly, I am concerned that the data on angiotensin converting enzyme (ACE) inhibitors, contradict convention. Secondly, without actual data in front of me, I have to guess at the meaning of the ACE inhibitor data.

    As the EUROPA, PROGRESS, ANBP, PEACE, TRACE, SAVE, and …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular